News Updates
More Articles
- Benefits of Integrating Patient Engagement with Diversity, Equity, and Inclusion in New Medical Product Development: A Call for Action
- Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
- Fair Pay for Patient Engagement: Navigating the Evolving Landscape of Remuneration
- Industry’s Window to Express Interest in Africa Continental Product Evaluation Pilot Closes End of February 2024
- The Importance of Regulatory Due Diligence During the Acquisition Process
Regulatory Agilities During the COVID-19 Pandemic Observations from a Multinational Pharmaceutical Company
The following practical actions were deployed by regulatory authorities and collectively experienced by industry to ensure the continued smooth functioning of regulatory systems during the pandemic. We propose that there is an imperative to continue to build on many of these actions to accelerate regulatory strengthening even further in international markets and to make some of these practices permanent.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!